A detailed history of Orbimed Advisors LLC transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 9,240,887 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,240,887
Previous 9,240,887 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
N/A
500,000 Added 5.72%
9,240,887 $0
Q4 2020

Feb 16, 2021

BUY
$25.0 - $46.34 $219 Million - $405 Million
8,740,887 New
8,740,887 $405 Million

Others Institutions Holding SBTX

About Silverback Therapeutics, Inc.


  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.